Iloperidone reduces sensorimotor gating deficits in pharmacological models, but not a developmental model, of disrupted prepulse inhibition in rats-Reference-Cited by-同舟云学术

Iloperidone reduces sensorimotor gating deficits in pharmacological models, but not a developmental model, of disrupted prepulse inhibition in rats

Published:2006-09 Issue:3 Volume:51 Page:457-465
ISSN:0028-3908
Container-title:Neuropharmacology
language:en
Short-container-title:Neuropharmacology

Author:

Barr Alasdair M.,Powell Susan B.,Markou Athina,Geyer Mark A.

Publisher

Elsevier BV

Subject

Cellular and Molecular Neuroscience,Pharmacology

Reference49 articles.

1. Acoustic startle and fear-potentiated startle in rats selectively bred for fast and slow kindling rates: relation to monoamine activity;Anisman;Eur. J. Neurosci.,2000

2. Antagonism of phencyclidine-induced deficits in prepulse inhibition by the putative atypical antipsychotic olanzapine;Bakshi;Psychopharmacology (Berl.),1995

3. Phencyclidine-induced deficits in prepulse inhibition of startle are blocked by prazosin, an alpha-1 noradrenergic antagonist;Bakshi;J. Pharmacol. Exp. Ther.,1997

4. Reversal of isolation rearing-induced deficits in prepulse inhibition by Seroquel and olanzapine;Bakshi;Biol. Psychiatry,1998

5. Psychostimulant withdrawal as an inducing condition in animal models of depression;Barr;Neurosci. Biobehav. Rev.,2005

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A scoping review of the effects of mushroom and fungus extracts in rodent models of depression and tests of antidepressant activity;Frontiers in Pharmacology;2024-06-03

2. Associations between antipsychotics exposure and dementia risk: A prospective cohort study of 415,100 participants;Journal of Affective Disorders;2024-03

3. Movement disorders associated with substance use in adults living in precarious housing or homelessness;Progress in Neuro-Psychopharmacology and Biological Psychiatry;2023-08

4. Medical cannabis and use in migraine;Medicinal Usage of Cannabis and Cannabinoids;2023

5. Chronic Treatment With Psilocybin Decreases Changes in Body Weight in a Rodent Model of Obesity;Frontiers in Psychiatry;2022-05-18